|TRUSTEES|I Campbell|
|---|---|
||I Mallinson|
||H Fryers|
||Dr D 5Tompkins|
||CThackray|
||E Podesta|
||Dr<br>I H Ca me ron|
||Professor BM Doyle|
|PRINCIPAL ADDRESS|The Thackray Museum ofMedicine|
||Beckett Street|
||Leeds|
||LS97LN|
|REGISTERED CHARITY NUMBER|1151361|
|AUDITORS|Thomas Coombs Limited|
||Statutory Auditor|
||Chartered<br>Accountants|
||3365The Pentagon|
||Century Way|
||Thorpe Park|
||Leeds|
||West Yorkshire|
||LS15BZB|
|BANKERS|Unity Trust Bank|
||PO BOX7193|
||Planetary<br>Road|
||Willenhag|
||WV1 9DG|
|5OUCITORS|Wrigleys Solicitors LLP|
||3Wellington<br>Place|
||Leeds|
||LS14AP|
|INVESTMENT MANAGERS|LGT|
||29 East Parade|
||Leeds|
||LS1SPS|





## 

## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

|The actual performance|The actual performance|afthe investment|portfolio compared|with the benchmark|has been:|
|---|---|---|---|---|---|
||||2022/2023||2021/2022|
|Investment|growth||o/a|||
|Benchmark —ARC|||-4.0%||+6.3%|
|Benchinark-|Income constrained||-2AN||+8.9%|
|Actual|||-5.1N||+8.636|



|his|toric|a|l value of|Trust Assets and Income has|been:|||
|---|---|---|---|---|---|---|---|
||||||Bank balance and|Income (after||
|||||Investment<br>Portfolio|Other Assets|management<br>posts)|Grants Awarded|
|5th|April||2023|67,941,764|613,010|E190,322|E205,540|
|scil|Apltl||2022|68,690,401|676,308|E178,077|E89,875|
|5th|April||2021|68,183,272|611,752|6159,070|E425,750|
|5th|April||2020|E7,010,915|692,441|E215,995|E235,000|
|5th|April||2019|E8,386,747|617,461|6219,660|6352,790|
|5th|April||2018|E7,968,271|634,532|E236,557|6794,550|
|5th|Apr|I|2017|E7,952,070|664,223|6209,916|6361,299|
|5th|April||2016|E6,928,672|f13,964|E225,888|6253,000|
|5th|April||2015|E7,449,783|E5,566|E202,436|E180,000|
|5th|April||2014|E6,941,780|68,332|6221,821|6201,800|
|5th|April||2013|E6,647,334|E8,047|6200,647|E161,500|
|5th|April||2012|65,947,384|65,213|6188,698|5200,162|



## 



## 

## 

## 

## 



## 

## 

## 



## 

||||2023|2022|
|---|---|---|---|---|
||||Unrestricted|Total|
||||fund|funds|
|||Notes|5|6|
|INCOME AND ENDOWMENTS|FROM||||
|Investment<br>income|||245,495||
|EXPENDITURE ON|||||
|Raising funds|||55,173|61,563|
|Charitable activities|||||
|Governance costs|||9,272|7,445|
|The Thackray Museum of Medicine|||188,540|79,200|
|Legs4 Af des|||2,000|2,000|
|Action Medical Research|||5,000|5,175|
|Haemochromatosis<br>UK||||3,500|
|Lepra|||5,000||
|Motivation<br>Charitable<br>Trust|||5,000||
|Total|||269,985|158,883|
|Net gains/(losses)<br>on investments|||(745,692)|531,590|
|NET INCOME/(EXPENDITURE)|||(770,182)|612,347|
|RECONCILIATION<br>OF FUNDS|||||
|Total funds brought forward|||8,695,811|8,083,464|
|TOTAL FUNDS CARRIED FORWARD|||7,925,629|8,695,811|





## 

||||2023|2022|
|---|---|---|---|---|
||||Unrestricted|Totoi|
|||Notes|fund<br>E|fundsf|
|FIXEDASSETS|||||
|Investments|||7,941,764|8,690,401|
|CURRENT ASSETS|||||
|Debtors||10|2,376|1,187|
|Cash at bank|||10,634|75,121|
||||13,010|76,308|
|CREDITORS|||||
|Amounts<br>falling due within one year|||{29,145)|(70,898)|
|NET CURRENT ASSETS|||{16,135)|5,410|
|TOTAL ASSETS LESSCURRENT UABILITIES|||7,925,629|8,695,811|
|NET ASSETS|||7,925,629|8,695,811|
|FUNDS|||||
|Unrestricted|funds||7,925,629|8,695,811|
|TOTAL FUNDS|||,9<br>,6||






## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 




## 

|GRANTS PAY|A8LE|||||
|---|---|---|---|---|---|
|||||2023|2022|
|||||E|6|
|The Thackray|Museum||of Medicine|188,540|79,200|
|Legs 4Africa||||2,000|2,000|
|Action Medical Research||||5,000|5,173|
|Haemochromatosls||UK|||3,300|
|Lepra||||5,000||
|Motivation<br>Charitable|||Trust|5,000||
|||||205,540|89,875|



|||Awarded<br>2022|Grants<br>unpaid at<br>06/04/22|Awarded<br>In<br>the year<br>ended 2023|Awarded<br>In<br>the year<br>ended 2023|Paid Inthe<br>year ended<br>2023|Grants<br>unpaid at<br>05/04/2023|
|---|---|---|---|---|---|---|---|
|The Thackray Medical|Museum|||||||
|Company<br>Ltd (trading|as The|||||||
|Thackray Museum of|Medicine)|||||||
|Re:Quarterly<br>grants||82,500|41,250|165,000||(206,250)||
|Archive Development|Project|||30,500||(22,875)|7,625|
|Scoping study for medical||||||||
|practitioners<br>listing project||(3,300)||||||
|Contdbutions<br>to new|collections|||||||
|management<br>system|||6,960|(6,960)||||
|OTHER FUNDING||||||||
|Haemochromatosis<br>UK Charity||3,500||||||
|Legs for Africa||2,000|2,000|2,000||(2,000)|2,000|
|Action Medical Research||5,175||5,000||(5,000)||
|Lepra||||5,000||(5,000)||
|Motivation<br>Charitable|Trust|||5,000||(5,000)||
|Total Grants Awarded||89,875|50,210|205,540||246,125|9(625|





## 

## 

## 

||||||Governance|
|---|---|---|---|---|---|
||||||costs|
||||||E|
|Governance||costs|||9,272|
|Support|costs, included||in the above, are asfollows:|||
|||||2023|2022|
|||||Governance|Total|
|||||costs|activities|
|||||E|6|
|Trustee|Meeting Expenses|||1,382|8629|
|Sundries||||838|23|
|Legs Ifees||||688|793|
|Auditors|Remuneration|||6,364|5,000|
|||||9,272||



## 

## 

## 

## 

|COMPARAllVES<br>FO|R THE STA|TEMENT OF FINANCIAL ACTIVITIES||
|---|---|---|---|
||||Unrestricted|
||||fund|
|INCOME AND ENDOWMENTS||FROM||
|Investment<br>income|||239,640|
|EXPENDITURE ON||||
|Raising funds|||61,563|
|Chaditable acdvities||||
|Governance<br>costs|||7,445|
|The Thackray Museum ofMedicine|||79,200|
|Legs 4Africa|||2,000|
|Action Medical Research|||5,175|
|Haemochromatosis|LIK||3,500|
|Total|||158,883|
|Net gains on investments|||531,590|
|NET INCOME|||612,347|





## 

|||||||Unrestricted|Unrestricted|
|---|---|---|---|---|---|---|---|
||||||||fund|
||||||||f|
|RECONCILIATION|OF FUNDS|||||||
|Total funds broughtforward|||||||8,083,464|
|TOTAL FUNDS CARRIED FORWARD|||||||8,695,811|
|FIXEDASSETINVESTMENTS||||||||
||||||Cash and|||
||||Listed|settlements||||
||||investments||pending||Totals|
||||E||E||E|
|MARKET VALUE||||||||
|At 6th Apnl 2022|||8,075,634||614,767|8,690A01||
|Additions|||1,152,751||105,784|1,258435||
|Disposals|||(1,514,635)|||(1,514,635)||
|Revaluations|||(492,537)||||(492,537)|
|At 5th April 2023|||7,221,213||720,551|7,941,764||
|NET 8OOK VALUE||||||||
|At 5th April 2023|||7,221313||720,551|7,941,764||
|At 5th April 2022|||8,075,634||624,767|8,690,402||
|There were no investment||assets outside the UK.||||||
|All investments<br>are va(ued||with reference to UK and non-UK investments|Rated on recognised||stock exchanges,||and can be|
|analysed<br>as follows:||||||||



|Fixed Interest|||12.595|
|---|---|---|---|
|Equities|||71.33fi|
|Alternatives|||9.196|
|Property|||1.334|
|Cash instruments|and liquidity|funds|5.89fi|
||||10N6|





## 

## 

|10.|DEBTORS:AMOUNTS|DEBTORS:AMOUNTS|FALLING DUE WITHIN ONE YEAR|FALLING DUE WITHIN ONE YEAR||||
|---|---|---|---|---|---|---|---|
|||||||2023|2022|
|||||||E|6|
||Other debtors|||||2,376|1,187|
|11.|CREDITORS.' AMOUNTS|||FALLING DUE WITHIN ONE YEAR||||
|||||||2023|2022|
|||||||E||
||Accrued expenses|||||19,520|20,688|
||Grants payable|||||9,625|50,220|
|||||||29,145|70,898|
|12.|MOVEMENT|IN FUNDS||||||
|||||||Net||
|||||||movement|At|
||||||At 6/4/22|In funds|5/4/23|
||||||E|E|E|
||Unrestricted|funds||||||
||General fund||||8,695,811|{770,182)|7,925,629|
||TOTALFUNDS||||8,6952I11|[770,182)|7,925,629|





## 

||||Incoming|Resources|Gains and|Movement|
|---|---|---|---|---|---|---|
||||resources<br>f|expended<br>f|losses<br>E|in funds<br>E|
|Unrestricted|funds||||||
|General fund|||245/I95|(269„rIBS)|{745,692)|(770,182)|
|TOTALFUNDS|||245,495|(269,985)|(745,692)|(770,182)|
|Comparatives|for movement|in funds|||||
||||||Net||
||||||move ment|At|
|||||At 6/4/21|in funds|5/4/22|
||||||f|f|
|Unrestricted|funds||||||
|General fund||||8,083,464|612,347|8,695,811|
|TOTAL FUNDS||||8,083,464|612,347|8,695,811|



|||Incoming|Resources|Gains and|Movement|
|---|---|---|---|---|---|
|||resources<br>f|expended<br>f|losses<br>f|in funds<br>f|
|Unrestricted|funds|||||
|Generalfund||239,640|(158,883)|531,590|612,347|
|TOTAL FUNDS||239,640|(158,883)|531,590|612,347|



## 

## 



## 

||||2023|2022|
|---|---|---|---|---|
||||6|6|
|INCOME AND ENDOWMENTS|||||
|Investment<br>income|||||
|Dividends<br>and similar<br>income received from listed|||||
|investments|||245395|239,640|
|Totalincoming<br>resources|||245,495|239,640|
|EXPENDITURE|||||
|Investment<br>management||costs|||
|Porffolio management|||55,173|61,563|
|Charitable<br>activities|||||
|Grants to institutions|||205,540|89,875|
|Support costs|||||
|Governance<br>costs|||||
|Trustee Meeting Expenses|||1,382|1,629|
|Sundries|||$38|23|
|Legalfees||||793|
|Auditors<br>Remuneration|||6,364|5,000|
||||9,272|7,445|
|Total resources expended|||269,985|158,883|
|Net (expenditure)/Income||before gains and losses|(24890)|80,757|
|Realised recognised<br>gains||and losses|||
|Unrealised<br>gains/losses|on fixed asset Investments||(492,537)|651,162|
|Realised gains/losses<br>on|fixed asset investments||(253,155)|(119,572)|
|Net (expenditure)/income|||(770,182)|612,347|